Company news

Cambium Bio Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

European Medicines Agency grants Progenza ATMP status

February 13, 2018

Japanese Patent Office to grant patent for cancer vaccine

February 11, 2018

Regeneus Announces Successful Results in Acne Study

February 6, 2018

CEO Presentation to 2017 Annual General Meeting

November 2, 2017

Sygenus shows longer lasting effect on pain than morphine

September 25, 2017

Regeneus receives R&D tax incentive refund of $2.6m

August 29, 2017

Appendix 4E Revised

August 22, 2017

US patent allowed for Sygenus for acne

July 9, 2017

RGS to receive milestone payment for successful Phase I

June 20, 2017

Japanese Patent Office to grant key patent for Progenza

May 23, 2017

Positive clinical trial results for Progenza

May 22, 2017

Chinese patent granted on stem cell secretions technology

March 27, 2017

Regeneus receives upfront payment of US$5.5m from AGC

January 22, 2017

Regeneus and AGC collaborate on Progenza in Japan

December 28, 2016

Japan Update

October 16, 2016

Regeneus receives R&D tax incentive refund of $2.7m

September 11, 2016

Appendix 4E and Annual Report 2016

August 23, 2016

European patent to grant on stem cell secretions for acne

August 1, 2016

ARC grant to progress stem cell research for chronic pain

May 16, 2016

Enrolment complete and positive safety in Progenza trial

May 15, 2016

Response to 7.30 media commentary

March 30, 2016

Appendix 4D and Half Yearly Report

February 28, 2016

Positive safety of first cohort in Progenza stem cell trial

February 11, 2016

Patent granted for cancer vaccine technology

February 10, 2016

← Newer news releases

Decks

The 5 newest of 7 decks. Every deck is listed under its year.